Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000501347 | SCV000594898 | likely benign | not specified | 2017-01-03 | criteria provided, single submitter | clinical testing | |
Mayo Clinic Laboratories, |
RCV004791500 | SCV005411786 | uncertain significance | not provided | 2024-04-29 | criteria provided, single submitter | clinical testing | BP4, PM1_supporting |
Ambry Genetics | RCV000501347 | SCV005594729 | uncertain significance | not specified | 2024-11-13 | criteria provided, single submitter | clinical testing | The c.1922T>C (p.V641A) alteration is located in exon 1 (coding exon 1) of the FYB gene. This alteration results from a T to C substitution at nucleotide position 1922, causing the valine (V) at amino acid position 641 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |